Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
International Prognostic Scoring System
Другие языки:

    International Prognostic Scoring System

    Подписчиков: 0, рейтинг: 0
    International Prognostic Scoring System
    Purpose Assess severity of myelodysplastic syndrome

    The International Prognostic Scoring System (IPSS), published in 1997, is used by many doctors to help assess the severity of a patient's myelodysplastic syndrome (MDS). Based on the IPSS score, the patient's history, and his/her personal observations, the physician will design a treatment plan to address the MDS.

    Process

    The IPSS uses three "prognostic indicators" to develop a "score" which may be useful in understanding how the MDS may progress:

    Each indicator is rated according to its severity and the ratings are combined into a "score."

    Scores are sorted into one of four risk categories:

    • low
    • intermediate-1
    • intermediate-2
    • high

    The two lower categories can be further described as the lower risk group while the two upper categories can be further described as the higher risk group.

    A revised IPSS, IPSS-R was published in 2012. IPSS-R is more refined in its prognostic precision and includes five instead of four prognostic groups.


    Новое сообщение